Study for Asthma Patients that are not Adequately Controlled on Current Treatment

What we are studying

This study aims to see whether patients who have certain genetic markers may respond better to a certain treatment. Genetic markers are genes [or DNA] and they are the genetic material contained in all the cells of your body, including blood cells. This genetic material affects such things as your physical features, hair, and eye color. In particular, the study will look at how response to this treatment is influenced by genetic differences in a gene called the interleukin 4 receptor.

Who we are studying

• Men and Women
• Races:
  • White
  • African American
  • Asian
  • American Indian or Alaska Native
  • Native Hawaiian or Pacific Islander
  • Other
• All Ethnicities
• Ages 18 - 61

Eligibility Criteria

• Diagnosed with asthma for at least one year
• Asthma which is not adequately controlled on current treatment

What is involved

• 2 screening visit
• 2 baseline visits
• 10 study visits
• 1 follow-up visit

Compensation:

Subjects will be paid $1470.00 if they complete all the scheduled study visits

Contact Information

Study Coordinator

Bob Hmieleski

Email

bhmieles@wakehealth.edu

Phone

336-713-8555